⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 17, 2026
Investdesk

NSE

Apollo Hospitals Enterprise LimitedAPOLLOHOSP

APOLLOHOSP₹8,427.5▼ 0.77% today
Nifty 50

Apollo Hospitals is India's largest private hospital chain.

Key productsHospitals, pharmacies (Apollo Pharmacy), diagnostics and digital health (Apollo 24/7).
GeographyIndia.
CompetitorsMax Healthcare, Fortis, Manipal, Narayana.

AI-generated overview — verify before relying on it.

Net institutional flow

+₹1,108.9 Cr

Institutional buyers

23 in / 0 out

High-impact filings

1 · tilt Neutral

Next corporate action

Interim Dividend - Rs 10 Per Sh

ex 2026-02-16

Competitive landscape — the read

vs mapped peers · 1Y
1M3M6M1Y2YAll
Institutional money is backing APOLLOHOSP hardest (+₹1,108.9 Cr net). APOLLOHOSP leads this set on institutional accumulation. Filing momentum favours ZYDUSLIFE (+1). News & social buzz is most positive on DRREDDY.
#CompanyInst. flow ₹CrDealsHi-impactFiling mom.BuzzNews
1APOLLOHOSPThis+₹1,108.9 Cr491———
2MAXHEALTH+₹0 Cr6————
3FORTIS+₹0 Cr10————
4CIPLA+₹0 Cr4——+1944
5DRREDDY+₹0 Cr4——+2046
6SUNPHARMA+₹0 Cr6——+1545
7TORNTPHARM——————
8LUPIN+₹0 Cr4————
9ZYDUSLIFE——1+1——

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

SWOT

Strengths

  • • Largest private hospital chain in India
  • • Strong brand presence across the country
  • • Diversified revenue streams through hospitals, pharmacies, and diagnostics
  • • Established partnerships with insurance companies and government entities

Weaknesses

  • • High operational costs due to large infrastructure investments
  • • Dependence on a few key markets (e.g., Hyderabad) for revenue growth
  • • Competition from public sector hospitals and emerging private players
  • • Regulatory challenges in the healthcare sector

Opportunities

  • • Growing demand for healthcare services in urban India
  • • Expansion into new markets, such as Southeast Asia
  • • Development of digital health platforms to increase patient engagement
  • • Partnerships with pharmaceutical companies to expand Apollo Pharmacy's product offerings

Threats

  • • Rising competition from public sector hospitals and private players like Max Healthcare
  • • Increasing regulatory scrutiny and potential changes in government policies
  • • Cybersecurity threats to Apollo 24/7's digital health services
  • • Pandemic-related disruptions to hospital operations and revenue streams

AI-generated from our data — verify before relying on it.

Timeline — APOLLOHOSP day by day

1M3M6M1Y2YAll
  1. 2026-06-16Filing Preetha Reddy has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities andShareholding Disclosure
  2. 2026-06-15FilingApollo Hospitals Enterprise Limited has informed the Exchange about Scheme of Arrangement - Additional informaM&A
  3. 2026-02-16ActionInterim Dividend - Rs 10 Per ShDividend
  4. 2025-11-19BlockSELL · ₹43.6 CrBOFA SECURITIES EUROPE SA
  5. 2025-11-19BlockBUY · ₹43.6 CrKADENSA MASTER FUND
  6. 2025-11-10BlockBUY · ₹69 CrBOFA SECURITIES EUROPE SA
  7. 2025-11-10BlockSELL · ₹69 CrGOLDMAN SACHS BANK EUROPESE-ODI
  8. 2025-09-17BlockSELL · ₹40.9 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
  9. 2025-09-17BlockBUY · ₹40.9 CrGOLDMAN SACHS BANK EUROPE SE - ODI
  10. 2025-09-15BlockSELL · ₹31.7 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
  11. 2025-09-15BlockBUY · ₹31.7 CrGOLDMAN SACHS BANK EUROPE SE - ODI
  12. 2025-09-09BlockSELL · ₹33.5 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
  13. 2025-09-09BlockBUY · ₹33.5 CrGOLDMAN SACHS BANK EUROPE SE - ODI
  14. 2025-08-22BulkSELL · ₹1,489.3 CrSUNEETHA REDDY
  15. 2025-08-22BlockBUY · ₹10.2 CrABU DHABI INVESTMENT AUTHORITY
  16. 2025-08-22BlockBUY · ₹45.5 CrAXIS MUTUAL FUND
  17. 2025-08-22BlockBUY · ₹10.2 CrBANK OF INDIA MUTUAL FUND
  18. 2025-08-22BlockBUY · ₹22 CrBNP PARIBAS FINANCIAL MARKETS
  19. 2025-08-22BlockBUY · ₹10.2 CrCOPTHALL MAURITIUS INVESTMENT LIMITED
  20. 2025-08-22BlockBUY · ₹1.5 CrDENDANA INVESTMENTS MAURITIUS LIMITED
  21. 2025-08-22BlockBUY · ₹336.2 CrEMERGING MARKETS EQUITY TRUST
  22. 2025-08-22BlockBUY · ₹52.8 CrFIDELITY FUNDS.- INDIA FOCUS FUND
  23. 2025-08-22BlockBUY · ₹4.6 CrFIDELITY INDIA FUND
  24. 2025-08-22BlockBUY · ₹180.6 CrGHISALLO MASTER FUND LP
  25. 2025-08-22BlockBUY · ₹10.2 CrGOLDMAN SACHS (SINGAPORE) PTE
  26. 2025-08-22BlockBUY · ₹5.7 CrINVESCO MUTUAL FUND
  27. 2025-08-22BlockBUY · ₹1.1 CrINVESCO MUTUAL FUND
  28. 2025-08-22BlockBUY · ₹4.4 CrINVESCO MUTUAL FUND
  29. 2025-08-22BlockBUY · ₹5.3 CrINVESCO MUTUAL FUND
  30. 2025-08-22BlockBUY · ₹25.1 CrKOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED
  31. 2025-08-22BlockBUY · ₹17.7 CrKOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED
  32. 2025-08-22BlockBUY · ₹1.2 CrKOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED
  33. 2025-08-22BlockBUY · ₹0.6 CrKOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED
  34. 2025-08-22BlockBUY · ₹0.3 CrKOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED
  35. 2025-08-22BlockBUY · ₹0.2 CrKOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED
  36. 2025-08-22BlockBUY · ₹0.2 CrKOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED
  37. 2025-08-22BlockBUY · ₹0.2 CrKOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED
  38. 2025-08-22BlockBUY · ₹63 CrMORGAN STANLEY ASIA SINGAPORE PTE
  39. 2025-08-22BlockBUY · ₹71.3 CrMORGAN STANLEY ASIA SINGAPORE PTE
  40. 2025-08-22BlockBUY · ₹3.7 CrMORNINGSTAR FUNDS TRUST - MORNINGSTAR INTERNATIONAL EQUITY FUND
  41. 2025-08-22BlockBUY · ₹257.5 CrSOCIETE GENERALE
  42. 2025-08-22BlockSELL · ₹1,489.3 CrSUNEETHA REDDY
  43. 2025-08-22BlockBUY · ₹0.2 CrT ROWE PRICE FUNDS SICAV GLOBAL ALLOCATION EXTENDED FUND
  44. 2025-08-22BlockBUY · ₹7.4 CrT ROWE PRICE FUNDS SICAV EMERGING MARKETS EQUITY FUND
  45. 2025-08-22BlockBUY · ₹0.1 CrT ROWE PRICE FUNDS SICAV GLOBAL ALLOCATION FUND
  46. 2025-08-22BlockBUY · ₹1.8 CrT ROWE PRICE GLOBAL ALLOCATION FUND
  47. 2025-08-22BlockBUY · ₹23.5 CrT ROWE PRICE INSTITUTIONAL EMERGING MARKETS EQUITY FUND
  48. 2025-08-22BlockBUY · ₹36.2 CrT ROWE PRICE RETIREMENT HYBRID TRUST- T ROWE PRICE NON US EQUITIES TRUST
  49. 2025-08-22BlockBUY · ₹258 CrT. ROWE PRICE EMERGING MARKETS STOCK FUND
  50. 2025-08-22BlockBUY · ₹0.3 CrT. ROWE PRICE GLOBAL ALLOCATION FUND
  51. 2025-08-22BlockBUY · ₹10.2 CrTATA MUTUAL FUND
  52. 2025-08-22BlockBUY · ₹10.2 CrVIRIDIAN ASIA OPPORTUNITIES MASTER FUND
  53. 2025-08-22NetDay net −₹1,489.3 Cr
  54. 2025-08-19ActionDividend - Rs 10 Per ShareDividend

Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.

Filings that matter

  • 2
    Shareholding DisclosureNeutral

    a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

    Source PDF →
  • 7
    M&ANeutral

    Scheme details provide clarity but likely no immediate share price impact.

    Source PDF →

Bulk & block deals

1M3M6M1Y2YAll

49 deals · 2025-08-22 → 2025-11-19

DateCounterpartyTypeSideValue
2025-11-19BOFA SECURITIES EUROPE SAProp / churnSELL₹43.6 Cr
2025-11-19KADENSA MASTER FUNDInstitutionBUY₹43.6 Cr
2025-11-10BOFA SECURITIES EUROPE SAProp / churnBUY₹69 Cr
2025-11-10GOLDMAN SACHS BANK EUROPESE-ODIHNI / otherSELL₹69 Cr
2025-09-17GOLDMAN SACHS (SINGAPORE) PTE - ODIHNI / otherSELL₹40.9 Cr
2025-09-17GOLDMAN SACHS BANK EUROPE SE - ODIHNI / otherBUY₹40.9 Cr
2025-09-15GOLDMAN SACHS (SINGAPORE) PTE - ODIHNI / otherSELL₹31.7 Cr
2025-09-15GOLDMAN SACHS BANK EUROPE SE - ODIHNI / otherBUY₹31.7 Cr
2025-09-09GOLDMAN SACHS (SINGAPORE) PTE - ODIHNI / otherSELL₹33.5 Cr
2025-09-09GOLDMAN SACHS BANK EUROPE SE - ODIHNI / otherBUY₹33.5 Cr

49 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.

News & chatter on APOLLOHOSP

RSS News

0

No recent news.

Google News RSS — links open the source.

Investdesk

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.